[Neurological phenocopying]
- PMID: 17160927
[Neurological phenocopying]
Abstract
Aims: To expand the -supposedly- narrow relationships that exist between genes and clinical syndromes by reflecting on several illustrative examples that disturb current simplistic genotype: phenotype correlations, and to explore a variety of biological mechanisms that account for this emerging phenomenon.
Development: Because it is well known that mutations in a single gene can give rise to numerous phenotypes, it would appear, at least intuitively, that the converse relationship might also hold true: that different genotypes may converge on just one single phenotype. Several examples taken from the study of selected neurological diseases illustrate that the latter principle indeed occurs in nature because disparate human genetic anomalies manifest similarly by exhibiting only a relatively limited phenotypic repertoire. This interesting biological phenomenon and vexing clinical problem is best described as phenocopying. Conditions such as spinal muscular atrophy, congenital glycosylation disorders, and mitochondrial diseases are but a few notorious examples of phenocopying.
Conclusion: The nervous system is endowed with a limited number of genes and of types of molecules and, especially during development, its functional repertoire, at least from an observable point of view, is also limited. Therefore, ample genotyping capabilities are necessary to avoid erring in the process of diagnostic attribution because of phenocopying.
Similar articles
-
Spinal muscular atrophy diagnostics.J Child Neurol. 2007 Aug;22(8):952-6. doi: 10.1177/0883073807305668. J Child Neurol. 2007. PMID: 17761649 Review.
-
Coinheritance of mutated SMN1 and MECP2 genes in a child with phenotypic features of spinal muscular atrophy (SMA) type II and Rett syndrome.Eur J Paediatr Neurol. 2007 Jul;11(4):235-9. doi: 10.1016/j.ejpn.2006.12.007. Epub 2007 Feb 5. Eur J Paediatr Neurol. 2007. PMID: 17276711
-
Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.J Med Chem. 2008 Feb 14;51(3):449-69. doi: 10.1021/jm061475p. Epub 2008 Jan 19. J Med Chem. 2008. PMID: 18205293
-
Clinical and genetic study of spinal muscular atrophies in Oman.J Child Neurol. 2007 Oct;22(10):1227-30. doi: 10.1177/0883073807306268. J Child Neurol. 2007. PMID: 17940251
-
Molecular mechanisms of spinal muscular atrophy.J Child Neurol. 2007 Aug;22(8):979-89. doi: 10.1177/0883073807305787. J Child Neurol. 2007. PMID: 17761653 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical